🎧 Catch Harry Clifford on "Behind The Breakthroughs: Carrying Medicine Into the Post-Moore’s Law Era" podcast. Chatting about the big challenges in precision medicine, and how accelerated computing and AI are powering advances in #NVIDIAhealthcare. bit.ly/4eXOWwU

Human digital twins?! Robots in healthcare?! NVIDIA, Mayo Clinic team up on AI-Powered Digital Pathology. Check my write up, featuring Kimberly Powell, VP Healthcare NVIDIA, and Jim Rogers, CEO Mayo Clinic Digital Pathology. #JPM2025 insideprecisionmedicine.com/topics/informa… Inside Precision Medicine

Been dreaming about their breakfast burrito for 2 years from Heist Coffee Company because they were closed for renovations last #JPMHC.

Women in science, medicine, and healthcare matter 🎀 #jpmorganhealthcareconference #jpmhc25 #JPM25

Dystopian moment … cab driver honking at an autonomous waymo taxi to make a right on red. #jpmhc25

Not gonna lie, patting myself on the back for the preheader of this title (reference to one of my fav books [Anthony Doerr] and biggest TV adaptation fails [Netflix]). Light We Cannot See: Quibim Nets $50M for AI-Powered Multimodal Biomarkers insideprecisionmedicine.com/topics/precisi… Inside Precision Medicine

In this episode, cell therapy expert Katy Rezvani, MD, PhD, (MD Anderson Cancer Center) tells me why she loves NK cells & the ways they’re being engineered to treat cancer and other diseases as accessible and affordable cell tx. shows.acast.com/67105af8487269… Inside Precision Medicine Mary Ann Liebert Inc

Join us for The State of Precision Medicine 2025 on March 5! At 2:30 p.m. ET, Inside Precision Medicine’s Jonathan D. Grinstein, PhD hosts a panel with Rollie Carlson (Immunexpress), Nigel McCracken (Virax Biolabs), and Lishan Aklog (Lucid Diagnostics) to discuss molecular diagnostics. Register for free:

Discover how @AllofUsCEO Josh Denny, MD, is harnessing diverse biological data to advance understanding of health disparities, rare diseases, and common conditions in this Behind the Breakthroughs episode by Inside Precision Medicine [Sage Publications]. NIH AllofUsResearch shows.acast.com/67105af8487269…

Official video with a general-audience summary of base editing and prime editing: m.youtube.com/watch?v=IMpczE… Breakthrough

Put Patrick Hsu (Patrick Hsu | Arc Institute), Serge Saxonov (10x Genomics), and Gilad Almogy (Ultima Genomics) under the same roof to chat about the “virtual cell”…chances are they’ll say a thing or two that’ll make your mind explode. Inside Precision Medicine, Sage Publications shows.acast.com/67105af8487269…

“I’m overwhelmed to see the pictures of KJ at home, with his family,” Kiran Musunuru MD, PhD, told Inside Precision Medicine. “…it just increases my determination to find ways to do the same for as many kids as possible.” Children's Hospital Danaher Corporation insideprecisionmedicine.com/topics/precisi…

“I thought I had to separate being a CEO and being a rare disease mom. I’ve learned I’m better at both when I embrace both.” In this deeply personal episode of 𝘽𝙚𝙝𝙞𝙣𝙙 𝙩𝙝𝙚 𝘽𝙧𝙚𝙖𝙠𝙩𝙝𝙧𝙤𝙪𝙜𝙝𝙨 podcast, Alltrna CEO Michelle Werner talks with Jonathan D. Grinstein, PhD about how

Mike Previte, Element Biosciences cofounder/CTO, is (Good) Will Hunting IRL. Check out Mike discuss why and how he's developing tools like 5D single-cell multiomics in the latest Inside Precision Medicine "Behind The Breakthroughs" episode out now! Acast: shows.acast.com/67105af8487269… SAGE Publications

On Thursday, the NIH dropped 2 news bombs: ending funding for animal-only research to prioritize human studies & publishing more >200 complete response letters to FDA applications for drugs/biologics during 2020-2024. Inside Precision Medicine want to hear your thoughts! DM/email/etc.

Brilliant collab of David R. Liu (Broad Institute / Harvard University) & Cat Lutz (The Jackson Laboratory) shows that durable in vivo primed editing of a neurodevelopmental disorder proves the feasibility of creating bespoke gene-editing drugs for a single disease in parallel. insideprecisionmedicine.com/topics/transla…

“Science guided by empathy transforms lives”

With the Sarepta Therapeutics sage regarding their muscular dystrophy gene therapies over the past week, this episode couldn't have had better timing... Amber Salzman explains how Epicrispr Bio is creating epigenetic editing drugs for genetic diseases that require finer network tuning than

As CRISPR, the most groundbreaking biotech discovery of the 21st century, gained traction, Janice Chen, enrolled as a graduate student in the lab of Nobel laureate Jennifer Doudna, PhD, at UC Berkeley. In contrast to the many scientists around the world who sought to use CRISPR